LLY Financial Facts
Cost of sales, operating expenses, and other-net: 4.22BCost of sales: 1.4B
See Full Income Statement
Dividends payable: 0
Less accumulated depreciation: -8.99B
See Full Balance Sheet
Eli Lilly (LLY) Earnings
|
Expand Research on LLY
| Next EPS Date | 4/30/24 | EPS Growth Rate | +51.9% |
|---|---|---|---|
| Average EPS % Beat Rate | +40.1% | Revenue Growth Rate | +28.2% |
| Average % Move 1-Wk after EPS | +12.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/30/24  |
Q124 | N/A | $2.46 | N/A | N/A | $8.92B | = | N/A | N/A | ||
| 2/6/24 | Q423 | $2.49 | $2.31 | +$0.18 | $9.35B | $8.95B | = |  | | Details | |
| 11/2/23 | Q323 | $0.10 | -$0.20 | +$0.30 | $9.5B | $8.97B |  |
| | Details | |
| 8/8/23 | Q223 | $2.11 | $1.98 | +$0.13 | $8.31B | $7.58B | |
| | Details | |
| 4/27/23 | Q123 | $1.62 | $1.69 | -$0.07 | $6.96B | $6.84B | |
| | Details | |
| 2/2/23 | Q422 | $2.09 | $1.80 | +$0.29 | $7.3B | $7.35B | |
| | Details | |
| 11/1/22 | Q322 | $1.98 | $1.91 | +$0.07 | $6.94B | $6.91B | = | | | Details | |
| 8/4/22 | Q222 | $1.25 | $1.71 | -$0.46 | $6.49B | $6.85B | = | | | Details |
